GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Insmed Inc (FRA:IM8N) » Definitions » Other Long-Term Liabilities

Insmed (FRA:IM8N) Other Long-Term Liabilities : €303.0 Mil (As of Mar. 2025)


View and export this data going back to 2000. Start your Free Trial

What is Insmed Other Long-Term Liabilities?

Insmed's other long-term liabilities for the quarter that ended in Mar. 2025 was €303.0 Mil.

Insmed's quarterly other long-term liabilities increased from Sep. 2024 (€289.2 Mil) to Dec. 2024 (€292.0 Mil) and increased from Dec. 2024 (€292.0 Mil) to Mar. 2025 (€303.0 Mil).

Insmed's annual other long-term liabilities increased from Dec. 2022 (€196.8 Mil) to Dec. 2023 (€222.6 Mil) and increased from Dec. 2023 (€222.6 Mil) to Dec. 2024 (€292.0 Mil).

Insmed Other Long-Term Liabilities Historical Data

The historical data trend for Insmed's Other Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Insmed Other Long-Term Liabilities Chart

Insmed Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Other Long-Term Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 7.55 84.73 196.83 222.63 292.01

Insmed Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Other Long-Term Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 205.93 244.39 289.23 292.01 302.96

Insmed Other Long-Term Liabilities Calculation

Other Long-Term Liabilities are the other liabilities on the balance sheet that do not need to be repaid within the next 12 months, but still need to be repaid over time. For instance, on Wal-Mart's balance sheet, there are items called Long Term obligations under capital leases, deferred income taxes, and redeemable non-controlling interest. These are all Other Long-Term Liabilities.

Insmed Other Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of Insmed's Other Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Insmed Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Insmed Inc (FRA:IM8N) » Definitions » Other Long-Term Liabilities
Comparable Companies
SMMT RPRX INCY BNTX EXEL BMRN MRNA ASND ONC BBIO VRTX ASX:CSL REGN XKRX:207940 ALNY XBRU:UCB XBRU:ARGX XKRX:068270 HKSE:01801 XKRX:196170
Traded in Other Exchanges
INSM:USA 0JAV:UK IM8N:Germany
Address
700 US Highway 202/206, Bridgewater, NJ, USA, 08807
Website
https://www.insmed.com
Insmed Inc is a biopharmaceutical company transforming the lives of patients with serious and rare diseases. The company's first commercial product is ARIKAYCE (amikacin liposome inhalation suspension), approved in the US for the treatment of Mycobacterium Avium Complex (MAC) lung disease as part of a combination antibacterial drug regimen for adult patients with limited or no alternative treatment options. It is also developing Brensocatib, an oral reversible dipeptidyl peptidase 1 inhibitor for bronchiectasis and other neutrophil-mediated diseases, and Treprostinil Palmitil Inhalation Powder, an inhaled treprostinil prodrug for pulmonary hypertension linked to interstitial lung disease and pulmonary arterial hypertension.

Insmed Headlines

No Headlines